| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2006-10-17 11:10:02 UTC |
|---|
| Update Date | 2022-03-07 02:49:25 UTC |
|---|
| HMDB ID | HMDB0005037 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Sumatriptan |
|---|
| Description | Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve. Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraines. Sumatriptan (Imitrex, Imigran, Imigran Recovery) is a triptan drug including a sulfonamide group which was originally developed by Glaxo for the treatment of migraine headaches. |
|---|
| Structure | CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1 InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide | ChEBI | | 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide | ChEBI | | 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide | ChEBI | | 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide | ChEBI | | Imigran | ChEBI | | Imitrex | ChEBI | | Sumatran | ChEBI | | Sumatriptanum | ChEBI | | Sumax | ChEBI | | (3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulphonamide | Generator | | 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide | Generator | | 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide | Generator | | 3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulphonamide | Generator | | Imigran recovery | HMDB | | Glaxo wellcome brand OF sumatriptan | HMDB | | Sumatriptan GSK brand | HMDB | | GSK Brand OF sumatriptan | HMDB | | Sumatriptan succinate | HMDB | | Succinate, sumatriptan | HMDB |
|
|---|
| Chemical Formula | C14H21N3O2S |
|---|
| Average Molecular Weight | 295.4 |
|---|
| Monoisotopic Molecular Weight | 295.135447621 |
|---|
| IUPAC Name | 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide |
|---|
| Traditional Name | sumatriptan |
|---|
| CAS Registry Number | 103628-46-2 |
|---|
| SMILES | CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1 |
|---|
| InChI Identifier | InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3 |
|---|
| InChI Key | KQKPFRSPSRPDEB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Tryptamines and derivatives |
|---|
| Direct Parent | Tryptamines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Aralkylamine
- Substituted pyrrole
- Organic sulfonic acid amide
- Benzenoid
- Organosulfonic acid amide
- Pyrrole
- Organic sulfonic acid or derivatives
- Heteroaromatic compound
- Organosulfonic acid or derivatives
- Aminosulfonyl compound
- Sulfonyl
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organosulfur compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 169 - 171 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | 0.93 | ADLARD,M ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 162.1 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.22 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.7157 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.18 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 120.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 536.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 225.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 119.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 172.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 82.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 251.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 270.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 857.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 667.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 66.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1023.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 214.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 665.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 482.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 107.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Sumatriptan,1TMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 2664.5 | Semi standard non polar | 33892256 | | Sumatriptan,1TMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 2646.5 | Standard non polar | 33892256 | | Sumatriptan,1TMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 3490.7 | Standard polar | 33892256 | | Sumatriptan,1TMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C | 2606.5 | Semi standard non polar | 33892256 | | Sumatriptan,1TMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C | 2627.0 | Standard non polar | 33892256 | | Sumatriptan,1TMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C | 3495.6 | Standard polar | 33892256 | | Sumatriptan,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 2657.9 | Semi standard non polar | 33892256 | | Sumatriptan,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 2783.2 | Standard non polar | 33892256 | | Sumatriptan,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C)C=C12 | 3259.5 | Standard polar | 33892256 | | Sumatriptan,1TBDMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 2880.8 | Semi standard non polar | 33892256 | | Sumatriptan,1TBDMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 2910.9 | Standard non polar | 33892256 | | Sumatriptan,1TBDMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 3494.4 | Standard polar | 33892256 | | Sumatriptan,1TBDMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C(C)(C)C | 2833.2 | Semi standard non polar | 33892256 | | Sumatriptan,1TBDMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C(C)(C)C | 2851.9 | Standard non polar | 33892256 | | Sumatriptan,1TBDMS,isomer #2 | CNS(=O)(=O)CC1=CC=C2C(=C1)C(CCN(C)C)=CN2[Si](C)(C)C(C)(C)C | 3509.5 | Standard polar | 33892256 | | Sumatriptan,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 3088.8 | Semi standard non polar | 33892256 | | Sumatriptan,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 3259.7 | Standard non polar | 33892256 | | Sumatriptan,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)C=C12 | 3334.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Sumatriptan GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zfr-7390000000-5809ad2270f77ffcec79 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sumatriptan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0a4i-9400000000-93cc7dc7e521f98aa292 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan LC-ESI-qTof , Positive-QTOF | splash10-03di-0190000000-c12ee3ac5f29c3420996 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan LC-ESI-qTof , Positive-QTOF | splash10-0a4i-2910000000-8769dc29dcac8fede7d1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan , positive-QTOF | splash10-0002-0390000000-cdddf05865e6d570c337 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan , positive-QTOF | splash10-0a4i-2910000000-8769dc29dcac8fede7d1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan 35V, Negative-QTOF | splash10-001i-1090000000-b0360ed354c3c7a76195 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sumatriptan 35V, Positive-QTOF | splash10-0a4i-7970000000-4a9c99ffaf927876bb55 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 10V, Positive-QTOF | splash10-000t-0090000000-42a6041e68fbb33f3c3c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 20V, Positive-QTOF | splash10-0uxr-1290000000-18f63d6714d369042ced | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 40V, Positive-QTOF | splash10-0a59-1910000000-b311f02f2295ff294573 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 10V, Negative-QTOF | splash10-0006-3090000000-23dacc0baf4eac1e818a | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 20V, Negative-QTOF | splash10-00mo-9280000000-45a6f0dbb82744e4f102 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 40V, Negative-QTOF | splash10-01r6-9120000000-ca48d4e064a2f6323651 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 10V, Negative-QTOF | splash10-03dl-9000000000-a75e9a0167fac95c8ca3 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 20V, Negative-QTOF | splash10-03dl-9530000000-af10011e851a42315cd8 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 40V, Negative-QTOF | splash10-0a4l-2900000000-e271d3cf647593f64e67 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 10V, Positive-QTOF | splash10-0002-0090000000-7a6d991d417845eb044c | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 20V, Positive-QTOF | splash10-0zg4-2890000000-0b86cdf68f0a940df967 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sumatriptan 40V, Positive-QTOF | splash10-0006-9510000000-e92db5fc8036751fb26f | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Pascual J, del Arco C, Romon T, del Olmo E, Castro E, Pazos A: Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia. 1996 Aug;16(5):317-22. [PubMed:8869766 ]
- Castro ME, Pascual J, Romon T, del Arco C, del Olmo E, Pazos A: Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology. 1997 Apr-May;36(4-5):535-42. [PubMed:9225278 ]
|
|---|